World’s first whole-eye and partial face transplant recipient is doing well
HQ Team September 10, 2024: Aaron James, 46, the first-ever person to undergo a combined whole-eye and partial face transplant, is doing well.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team September 10, 2024: Aaron James, 46, the first-ever person to undergo a combined whole-eye and partial face transplant, is doing well.
People with a history of damage to the lining of their upper gastrointestinal (GI) tract are at a 76% higher risk of developing.
Sudan’s civil war is a “nightmare” and the World Health Organization has called on the international community to broker peace and provide the.
EQT Private Capital Asia will acquire a controlling stake in GeBBS Healthcare Solutions, a provider of healthcare outsourcing solutions from ChrysCapital, according to.
Summit Therapeutics Inc.’s investigational drug ivonescimab helps lung cancer patients to cut the risk of progression or death from the disease by 48%,.
India suspects a young male to be infected with mpox after he travelled to a country currently in the grip of the disease,.
September 6, 2024: UK pharmaceutical giant GSK (GSK.L) announced that its asthma medicine, Nucala (mepolizumab), has shown positive results in a late-stage clinical.
HQ Team September 6, 2024: The National Medical Products Administration (NMPA) of China has suspended the import, sale, and use of Dr Reddy’s.
Falling global wages, possibly driven by automation and artificial intelligence, will slow the pace of achieving Sustainable Development Goals (SDG) as the 2030.
The World Health Organization expects the first delivery of mpox vaccines, made by Bavarian Nordic and donated by the European Union, today in.